Return to Article Details THE ROLE OF SEVERAL ¹⁸F-FDG PET/CT METABOLIC PARAMETERS IN PREDICTING TREATMENT RESPONSE FOLLOWING CONCURRENT CHEMORADIOTHERAPY IN PATIENTS WITH STAGE III ESOPHAGEAL CANCER Download Download PDF